Published: May 09, 2020, 23:40 IST | Updated: May 09, 2020, 23:40 IST
The U.S. Department of Health and Human Services (HHS) said on Saturday it would allow state health departments to distribute Gilead Sciences Inc's remdesivir drug to fight COVID-19, and the United States would receive about 40% of the drug maker's global donation.